Synergistic Embolic Capture Systems for Enhanced Treatment of Blocked Blood Vessels
Legal Citation
Summary of the Inventive Concept
Integrating AI, IoT, blockchain, and advanced materials with catheter-based emboli removal systems to create more effective, personalized, and secure treatment options for blocked blood vessels.
Background and Problem Solved
The original patent disclosed catheter-based emboli removal devices, but these systems had limitations in terms of real-time detection, secure data storage, and personalized treatment. The new inventive concept addresses these limitations by combining the original device with distinct technologies to create a more powerful system.
Detailed Description of the Inventive Concept
The synergistic embolic capture system comprises a catheter-based emboli removal device, an AI-powered diagnostic module for real-time blood clot detection, an IoT sensor system for monitoring device performance, a blockchain-based secure data storage system for patient treatment information, and advanced materials such as nanomaterial-coated mesh baskets for enhanced emboli capture. The system enables medical professionals to provide personalized treatment recommendations based on AI-powered image analysis, track patient outcomes, and identify trends using a secure data analytics platform.
Novelty and Inventive Step
The new claims introduce novel combinations of AI, IoT, blockchain, and advanced materials with catheter-based emboli removal systems, providing a non-obvious and significant improvement over the original patent. The integration of these distinct technologies enables real-time detection, secure data storage, and personalized treatment, which were not possible with the original device.
Alternative Embodiments and Variations
Alternative embodiments of the synergistic embolic capture system could include variations in the AI-powered diagnostic module, such as using machine learning algorithms for predicting treatment outcomes or incorporating natural language processing for enhanced patient communication. Other variations could involve different advanced materials or IoT sensor configurations to optimize device performance and patient safety.
Potential Commercial Applications and Market
The synergistic embolic capture system has significant commercial potential in the medical device industry, particularly in the treatment of blocked blood vessels, ischemic stroke, deep vein thrombosis, and pulmonary embolism. The system's ability to provide personalized treatment recommendations, track patient outcomes, and ensure secure data storage makes it an attractive solution for healthcare providers and patients alike.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61B17/22012 |
| A | A61 | A61B17/221 |
| A | A61 | A61B2017/22038 |
| A | A61 | A61B2017/22084 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Interventional medical devices, specifically catheter-based embolic capture systems for vascular treatment, requiring expertise in medical device design, interventional radiology, and minimally invasive surgical techniques
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or interventional radiologist with advanced knowledge of medical device design, familiarity with catheter-based technologies, understanding of vascular anatomy, and experience with emerging medical technologies
Obviousness Rationale
A person having ordinary skill in the art would recognize that integrating digital technologies like AI, IoT, and blockchain with existing medical device designs represents a predictable extension of current medical technology trends. The fundamental mechanical design of the embolic capture device remains consistent with the source patent, while the proposed technological enhancements represent incremental improvements in diagnostic and treatment monitoring capabilities. These variations would be considered obvious combinations of known techniques in medical device development and digital health technologies.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,209 |
|---|---|
| Title | Devices and methods for treating blocked blood vessels |
| Assignee(s) | SHANGHAI WALLABY MEDICAL TECHNOLOGIES CO., INC. |